You just read:

Kinex Pharmaceuticals Announced that the U.S. Food and Drug Administration has Granted Orphan Drug Status to KX02 for the Treatment of Gliomas

News provided by

Kinex Pharmaceuticals

Dec 04, 2013, 10:00 ET